(NASDAQ: NAUT) Nautilus Biotechnology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 86.28%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.76%.
Nautilus Biotechnology's revenue in 2025 is $0.On average, 2 Wall Street analysts forecast NAUT's revenue for 2025 to be $464,586,671, with the lowest NAUT revenue forecast at $25,112,793, and the highest NAUT revenue forecast at $904,060,548.
In 2026, NAUT is forecast to generate $2,104,828,745 in revenue, with the lowest revenue forecast at $2,104,828,745 and the highest revenue forecast at $2,104,828,745.